InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: None

Friday, 04/20/2018 12:28:09 PM

Friday, April 20, 2018 12:28:09 PM

Post# of 6378
Has recruiting has begun for the CML combination trial? Did I miss the press release? The BPTH web-site says:


"The dose determining segment of the Phase 2 clinical trial for prexigebersen in combination with the CML frontline therapy, dasatinib, is preparing to enroll patients for treatment."

Yet the FDA says "recruiting."


https://clinicaltrials.gov/ct2/show/NCT02923986?term=bio-path+CML&rank=1

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News